InhaleRx (ASX:IRX) Total Liabilities : A$0.63 Mil (As of Jun. 2024)

View and export this data going back to 2017. Start your Free Trial

What is InhaleRx Total Liabilities?

InhaleRx's Total Liabilities for the quarter that ended in Jun. 2024 was A$0.63 Mil.

InhaleRx's quarterly Total Liabilities increased from Jun. 2023 (A$0.47 Mil) to Dec. 2023 (A$0.91 Mil) but then declined from Dec. 2023 (A$0.91 Mil) to Jun. 2024 (A$0.63 Mil).

InhaleRx's annual Total Liabilities increased from Dec. 2021 (A$0.25 Mil) to Dec. 2022 (A$0.36 Mil) and increased from Dec. 2022 (A$0.36 Mil) to Dec. 2023 (A$0.91 Mil).

InhaleRx Total Liabilities Historical Data

The historical data trend for InhaleRx's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

InhaleRx Total Liabilities Chart

InhaleRx Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Liabilities

Get a 7-Day Free Trial

0.28

0.58

0.25

0.36

0.91

InhaleRx Semi-Annual Data
	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Total Liabilities	Get a 7-Day Free Trial										0.34	0.36	0.47	0.91	0.63

InhaleRx Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

InhaleRx's Total Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	0.911	+	(0	+	0
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	0.91

Total Liabilities	=	Total Assets (A: Dec. 2023 )	-	Total Equity (A: Dec. 2023 )
	=	1.577	-	0.665
	=	0.91

InhaleRx's Total Liabilities for the quarter that ended in Jun. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	0.633	+	(0	+	0.001
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	0.63

Total Liabilities	=	Total Assets (Q: Jun. 2024 )	-	Total Equity (Q: Jun. 2024 )
	=	0.582	-	-0.052
	=	0.63

InhaleRx Total Liabilities Related Terms

Thank you for viewing the detailed overview of InhaleRx's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

InhaleRx Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » InhaleRx Ltd (ASX:IRX) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

N/A

Address

126 Phillip Street, Level 5, Sydney, NSW, AUS, 2000

Website

https://www.inhalerx.com.au

InhaleRx Ltd focuses on medical inhalation devices for the delivery of prescribed medicines. The Medihale Inhaler utilizes heat (not burn) technology, avoiding the production of pyrolytic toxins and carcinogenic often created when combusting plant material such as tobacco or cannabis leaves of flowers. The sealed tamper-proof Medihale Pods provide patients with the additional security that the Medical Cannabis c-liquid is of good quality.

InhaleRx Headlines

No Headlines